United Therapeutics (UTHR) Tops Q4 EPS Views
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $544.23 +1.10%
EPS Growth %: +12.6%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +12.6%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.68, $1.13 better than the analyst estimate of $2.55. Revenue for the quarter came in at $404.9 million versus the consensus estimate of $388.29 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Deutsche Bank Starts DexCom (DXCM) at Buy
- Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
